Pharma Surge

Pharma Surge

🌍·8h agodiscovery

Singapore-based biotech startup Tikva Allocell closes $8 M Series A funding round

Publisher

B
BioSpectrum Asia

Global

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
BioSpectrum Asia
Region
Global
Scope
discovery
Published
July 22, 2026
Language
EN

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on news.google.com

Leave the platform to read the original full article on the publisher site.

Source: BioSpectrum Asia

Scope: discovery

Open original article
Singapore-based biotech startup Tikva Allocell closes $8 M Series A funding round | Pharma Surge